Klencke Barbara 4
4 · TScan Therapeutics, Inc. · Filed Aug 27, 2024
Insider Transaction Report
Form 4
Klencke Barbara
Director
Transactions
- Purchase
Voting Common Stock
2024-08-23$5.69/sh+5,000$28,450→ 35,000 total - Purchase
Voting Common Stock
2024-08-26$5.53/sh+5,000$27,650→ 40,000 total
Holdings
- 25,000(indirect: By Trust)
Voting Common Stock
Footnotes (1)
- [F1]Shares held by the Klencke Huestis Trust, for which the Reporting Person serves as co-trustee along with her spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.